“How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.”

— Robert G. Allen

Jeff Bishop

Bullseye or missing the mark? What’s your strategy

Bullseye or missing the mark? What’s your strategy

Sponsored By Hey Boardroom!How do you make private investing decisions? What’s your history?  One of the first private investments I made was about ten years ago in a small local startup in the athletic apparel space featured in CircleUp (crowdfunding was new at the...

What’s on my 17-year old’s Christmas list?

What’s on my 17-year old’s Christmas list?

Sponsored By Hey Boardroom!So YES Christmas is right around  the corner…and as I have three kids, my wife has to put some thought into what to get them – lol just kidding… But this weekend she did ask them to send her a screenshot/link for any gift requests – and...

We never invited FTX to the Boardroom

We never invited FTX to the Boardroom

Hey Boardroom!Every once in a while I’m reminded of the immortal words of Mark Twain, “History doesn’t repeat but it often rhymes.” Considering that we’ve all lived through some serious history in the 2020s, that adage feels more relevant than ever.One of the best...

See who else has stumbled on this HOT startup 🔥

See who else has stumbled on this HOT startup 🔥

Sponsored By:  Good day, Boardroom! This edition is a long one but a good opportunity to share some excerpts from ALTS’ world-class Deep Dive for RYSE, written by Stefan Von Imhof… But before we get to that…Boardroom and ALTS are not the only fans of this hot startup...

This tiny biotech stock is flashing a bullish signal

This tiny biotech stock is flashing a bullish signal

      Sponsored By         Since it was so important, I want to recap last week’s big Alzheimer’s news again. If you recall, lecanemab's developers were among the biggest stock market beneficiaries of Clarity-D’s topline readout, but...

Sally O’Malley would be a MyMD superfan

Sponsored by:   Hey guys and gals,  If you have been watching or trading MYMD the last few weeks, it has been a painful reminder that high-flying stocks can also come back down just as quickly. The good news is that MYMD is trading back at key support levels not...

Betting on SNPX

Betting on SNPX

      Sponsored By       Hello again, Trader! Yes, I’ve been talking a lot about Synaptogenix (SNPX) lately, and yes, I know the trading has been disappointing to say the least the last few days. In times like this when the market tests...

This Biotech company caught my eye

This Biotech company caught my eye

  Sponsored by:     If you’ve been following our updates, you know that MYMD-1® seeks to target the CAUSE, not just the symptoms, that drive autoimmunity and inflammation. However, did you also know that MYMD-1® may behave like an ANTIDEPRESSANT? This...

RYSE and Shine!

RYSE and Shine!

      Sponsored By:  Want to invest in the next big brand name in your home and get in on the ground floor of an innovative technology company? Meet RYSE. RYSE is the first retrofit solution to motorize and automate installed window blinds and shades,...

Could a cure be around the corner 🤔

Could a cure be around the corner 🤔

      Sponsored By         Do you know someone suffering from Alzheimer’s or has lost their fight with it? It’s likely you do, as 1 in 3 seniors dies with Alzheimer's (AD) or another dementia -- which kill more than breast cancer and...